# Aquestive Therapeutics, Inc.: Form DEF 14A, filed Apr 25, 2025

- Company: [Aquestive Therapeutics, Inc.](/companies/aqst.md) (CIK 1398733)
- Form: DEF 14A
- Filed: 2025-04-25
- Accepted by EDGAR: Apr 25, 2025, 16:31 ET
- Period: 2025-06-11
- Accession: 0001140361-25-015781
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1398733/000114036125015781/ny20043036x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1398733/000114036125015781/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1398733/000114036125015781/ny20043036x1_def14a.htm

Filed Apr 25, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-015781. Last ingested by Listed: Nov 13, 2026, 16:06 ET. No prices; not investment advice.